Mark B. Carbeau

Mark B. Carbeau

63 year
Health Technology
Distribution Services
Consumer Services

Profile

Mark B.
Carbeau
is the founder of CM Partners LLC, Diagnostyx, Inc. He was the Chief Executive Officer of Interleukin Genetics, Inc. in 2015, Chairman & Chief Executive Officer of Nuvesse Skin Therapies, Inc. in 2013, President & Chief Executive Officer of HyperMed, Inc. in 2008-2009, and President-USA Division of Kinetic Concepts, Inc. in 2005-2007.
He also worked as a Marketing Officer at Eli Lilly & Co. and as a Vice President-Corporate Development at OraPharma, Inc. He started his career as a Manager at The Boston Consulting Group, Inc. He holds an undergraduate degree from The Pennsylvania State University and an MBA from The Wharton School of the University of Pennsylvania.

Former positions of Mark B. Carbeau

CompaniesPositionEnd
INTERLEUKIN GENETICS, INC Chief Executive Officer 23/07/2017
Chief Executive Officer 31/05/2013
Chief Executive Officer 06/10/2009
Corporate Officer/Principal 29/06/2007
Director/Board Member -
See the detail of Mark B. Carbeau's experience

Training of Mark B. Carbeau

The Pennsylvania State University Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark B. Carbeau's experience

Connections

36

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
ELI LILLY AND COMPANY

Health Technology

Private companies9

Health Technology

Distribution Services

Health Technology

Commercial Services

Distribution Services

Health Technology

Diagnostyx, Inc.

Commercial Services

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Mark B. Carbeau